Table 1 Patient characteristics
From: Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma
Responders | Non-responders | Chi-statistic | p-value | |
|---|---|---|---|---|
Sex | 0.026 | 0.8721 | ||
Male | 14 | 62 | ||
Female | 4 | 16 | ||
AGE | 0.027 | 0.8688 | ||
<=55 | 10 | 45 | ||
>55 | 8 | 33 | ||
Fuhrman Grade | 0.074 | 0.7862 | ||
1-2 | 4 | 13 | ||
3-4 | 10 | 39 | ||
Tumor Size | 1.311 | 0.2522 | ||
<=75 mm | 9 | 23 | ||
>75 mm | 5 | 26 | ||
Performance Status | 0.087 | 0.7682 | ||
0 | 9 | 36 | ||
>1 | 9 | 42 | ||
LDH | 0.325 | 0.5686 | ||
Normal | 17 | 64 | ||
Elevated | 1 | 7 | ||
Calcium | 1.343 | 0.2465 | ||
Normal | 18 | 66 | ||
Elevated | 0 | 5 | ||
Hemoglobin | 0.464 | 0.4956 | ||
Normal | 12 | 53 | ||
Low | 6 | 18 | ||